Status:
COMPLETED
Analgesic Effects of Gabapentin and Paracetamol
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Hand Injuries
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This research is about the effects of drug gabapentin; which is an amino acid that is structurally similar to neurotransmitter GABA. It is a novel drug used for the treatment of postoperative pain wit...
Detailed Description
Gabapentin is an anti-convulsion medication and has a high affinity for voltage-gated calcium channel throughout the brain, acts by inhibition of release of excitatory neurotransmitters. As a lipophil...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients between 18-60 years of age
- Patients Undergoing hand surgery in the Department of Plastics and Reconstructive Surgery, Dr. Ruth KM Pfau Civil Hospital Karachi, Dow University of Health Sciences
- Exclusion criteria:
- Pregnant women
- Any patient presenting with the signs of:
- Arrhythmia
- Myocardial ischemia
- Cognitive impairment
- Psychiatric disorders
- Drug abuse
- Patients sensitive to any epileptic drug or taking any anti-epileptic drug
- Having severe and multiple injuries.
Exclusion
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2020
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04068506
Start Date
September 1 2019
End Date
January 21 2020
Last Update
January 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Ruth K.M. Pfau Civil Hospital Karachi
Karachi, Sindh, Pakistan